Description de l'entreprise
Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, and rare diseases. With the right combination of size and agility, the company continue to push themselves as a business and as individuals to deliver positive change.
Conseil d'administration & Conseil de surveillance
| PDG |
| David Loew |
| Conseil d'administration |
| Yan Moore M.D., Aymeric Le Chatelier, Aidan Murphy Ph.D., Craig Marks, Francois Garnier, Gwenan White, Regis Mulot, Dominique Bery, Alexander McEwan |
| Conseil de surveillance |
| - |
Données de l'entreprise
| Nom: |
Ipsen SA |
| Adresse: |
65, quai Georges Gorse,65, quai Georges Gorse Boulogne-Billancourt 92100 |
| Téléphone: |
+33 1 58 33 50 00 |
| Fax: |
- |
| Courriel: |
-
|
| Internet: |
https://www.ipsen.com |
| Industrie: |
Biotechnology |
| Secteur: |
Biotechnology |
| Sous-secteur: |
Biotechnology |
| Fin de l'exercice financier: |
31/12 |
| Flotte libre: |
41.52% |
| IPO date: |
01/12/2005 |
Relations avec les investisseurs
| Nom: |
Craig Marks |
| Téléphone IR: |
+44 7584 349 193 |
| IR-Fax: |
- |
| E-mail IR: |
-
|
